… This review summarizes the current data surrounding curcumin-mediated epigenetic
modulation … for curcumin's promise as an epigenetic agent for cancer therapy drug development. …

… balance recently became an attractive approach to develop new strategies in cancer … ,
appears as an interesting epigenetic agent 31-33. Curcumin or diferuloylmethane, extracted from …

… The development of curcumin for clinical use as a regulator of epigenetic changes, however,
… such as curcumin have great potential as epigenetic agents. Unlike genetic changes, …

… serving as a chemopreventive agent. Among these curcumin-induced epigenetic alterations
is … In addition to their pivotal role in the development of an organism, deregulated epigenetic …

… of curcumin by development of novel curcumin analogs with … for curcumin, and combination
therapy of curcumin with other … Curcumin is reportedly a potent DNA hypomethylation agent …

… The development of curcumin as a clinical … two agents in a sequential way. The sequential
release of both of these hypo-methylating agents maximized epigenetic activity of curcumin for …

… plays a major role in AML development. However, the mechanism by which … curcumin is a
potent epigenetic regulatory agent in many solid tumors. As a potent DNMT inhibitor, curcumin …

… epigenetic modulators of curcumin and analogs for prevention of metabolic diseases, and
accelerate development of … studies demonstrated that curcumin is a hypomethylation agent [37-…

… of myeloid and lymphoid cell lineages and was implicated in the development of … leads
to epigenetic changes in human and murine AML blasts and accelerated the development of …

… Curcumin is an ideal chemopreventive and antitumor agent characterized by poor
bioavailability and low stability. The development of synthetic structural analogues like …